Andrew Duncombe

4.3k citations
36 papers · 2.0k · 1 hit paper · h-index 18

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 17
    • Chronic Lymphocytic Leukemia Research 9
    • Hemoglobinopathies and Related Disorders 3
    • Acute Myeloid Leukemia Research 9
    • Chronic Myeloid Leukemia Treatments 7
    • Hematopoietic Stem Cell Transplantation 3

Andrew Duncombe

33 papers receiving 2.0k citations

Andrew Duncombe's Hit Papers

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders 2010 · 812 citations
8120+5+10Years since publication250500750

Peers

Andrew Duncombe
Comparison fields: 5 of 78
  • Hematology 999
  • Genetics 887
  • Rheumatology 229
  • Molecular Biology 1.1k
  • Cancer Research 118
Replace Hadrian Szpurka with:
Hadrian Szpurka United States
Rajko Kušec Croatia
Guillermo Garcia‐Manero United States
Stephen E. Langabeer Ireland
Nadine Carbuccia France
N Philippe France
Jean‐Luc Laï France
Thomas Cluzeau France
Giovanna Rege‐Cambrin Italy
Nathalie Grardel France
Andrew Duncombe relative to Hadrian Szpurka United States Hadrian Szpurka's profile →
Citations per field
00.5×1.5×2.3×
Hadrian Szpurka · 1×
Citations per year

Countries citing papers authored by Andrew Duncombe

Since Specialization
Citations

This map shows the geographic impact of Andrew Duncombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Duncombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Duncombe more than expected).

Fields of papers citing papers by Andrew Duncombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Duncombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Duncombe. The network helps show where Andrew Duncombe may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Duncombe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Duncombe Line = papers co-authored together Andrew Duncombe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Hit paper breakdown →
2010812
2 2011201
3 2009154
4 2014149
5 200199
6 201787
7 201583
8 201271
9 201149
10 201135
11 201534
12 201533
13 199132
14 201431
15 200629
16 202025
17 199723
18 201722
19 200816
20 200013

About Andrew Duncombe

Andrew Duncombe is a scholar working on Genetics, Hematology, Molecular Biology, Oncology and Immunology, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (9 papers), Kruppel-like factors research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Hematopoietic Stem Cell Transplantation (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). The work is most often cited by research in Hematology (999 citations), Genetics (887 citations), Rheumatology (229 citations), Molecular Biology (1.1k citations) and Cancer Research (118 citations). Andrew Duncombe has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Nicholas C.P. Cross, Claire Hidalgo-Curtis, Katerina Zoi, Amy V. Jones, Francisco Cervantes, Andreas Reiter, Thomas Ernst, Joannah Score, David Oscier and Jacqueline Boultwood. Their work appears in journals such as Blood, American Journal of Hematology, British Journal of Haematology, Leukemia and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact